Peripartum cardiomyopathy: The need for a national database

Netherlands Heart Journal

Volumn 19, Issue 3, 2011, Pages 126-133

  Lok, S I ^a   Kirkels, J H ^a   Klopping C ^a   Doevendans, P A F ^a   de Jonge, N ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Bromocriptine; Cardiomyopathy; Database; Peripartum

Indexed keywords

AMIODARONE; BIOLOGICAL MARKER; BROMOCRIPTINE; HEPARIN; STAT3 PROTEIN; WARFARIN;

APOPTOSIS; ASSISTED CIRCULATION; CARDIOVASCULAR RISK; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; GENETIC RISK; GROWTH RETARDATION; HEART MUSCLE BIOPSY; HEART PROTECTION; HEART TRANSPLANTATION; HEART VENTRICLE ARRHYTHMIA; HEMODYNAMIC STRESS; HUMAN; HYPERTHYROIDISM; IMMUNOPATHOGENESIS; MYOCARDITIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PERIPARTUM CARDIOMYOPATHY; PHYSICAL EXAMINATION; PROGNOSIS; PROTEIN FUNCTION; REVIEW; RISK ASSESSMENT; THROMBOEMBOLISM;

EID: 79955404690     PISSN: 15685888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12471-011-0083-7     Document Type: Review

References (34)

1. Bosch MGE, Santema JG, van der Voort PHJ, et al. A serious complication in the puerperium: peripartum cardiomyopathy. Neth Heart J. 2008;16:415-8.
2. Oosterom L, de Jonge N, Kirkels J, et al. Left ventricular assist device as a bridge to recovery in a young woman admitted with peripartum cardiomyopathy. Neth Heart J. 2008;16:426-8.
3. Murali S, Marie M, Baldisseri M. Peripartum cardiomyopathy. Crit Care Med. 2005;33:340-6.
4. Pearson G, Veille J, Rahimtoola S, et al. Peripartum cardiomyopathy: National Heart, Lung and Blood Institute and office of rare diseases (National Institute of Health) workshop recommendations and review. JAMA. 2000;283:1183-188.
5. Forssell G, Laska J, Olofsson C, et al. Peripartum cardiomyopathy:three cases. J Intern Med. 1994;235:493-6.
6. Elkyam U, Akhter MW, Singh H, et al. Pregnancy-associated cardiomyopathy. Clinical characteristics and a comparison between early and late presentation. Circulation. 2005;111:2050-5.
7. Sliwa K, Fett J, Elkayam U. Peripartum cardiomyopathy. Lancet. 2006;368:687-93.
8. Mayosi BM. Contempory trends in the epidemiology and management of cardiomyopathy and pericarditis in sub-Saharan Africa. Heart. 2007;93:1176-83.
9. Fett JD, Christie LG, Carraway RD, et al. Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. Mayo Clin Proc. 2005;80:1602-6.
10. Bultmann BD, Klingel K, Nabauer M, et al. High prevalence of viral genomes and inflammation in peripartum cardiomyopathy. Am J Obstet Gynecol. 2005;193:363-5.
11. Felker GM, Jaeger CJ, Klodas E, et al. Myocarditis and long-term survival in peripartum cardiomyopathy. Am Heart J. 2000;140:785-91.
12. Rizeq MN, Rickenberger PR, Fowler MB, et al. Incidence of myocarditis in peripartum cardiomyopathy. Am J Cardiol. 1994;74:474-7.
13. Nelson J. Pregnancy, persistent microchemerism and autoimmune disease. J Am Med Women Assoc. 1998;53:31-6.
14. Ansari A, Neckelman N, Wang Y, et al. Immunologic dialogue between cardiac myocytes, endothelial cells and mononuclear cells. Clin Immunol Immunopathol. 1993;68:208-14.
15. Sliwa K, Skudicky D, Bergman A, et al. Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1. J Am Coll Cardiol. 2000;35:701-5.
16. Gonzalez AM, Osorio JC, Manlhiot C, et al. Hypertrophy signaling during peripartum cardiac remodeling. Am J Physiol Heart Circ Physiol. 2007;293:3008-13.
17. Hayakawa Y, Chandra M, Miao W, et al. Inhibition of cardiac myocyte apoptosis improves cardiac function and abolishes mortality in the peripartum cardiomyopathy of Gαq transgenic mice. Circulation. 2008;117:396-404.
18. Meyer GP, Labidi S, Podewski E, et al. Bromocriptine treatment associated with recovery from peripartum cardiomyopathy in siblings: two case reports. J Med Case Rep. 2010;4:80.
19. Spaendonck-Zwarts KY, van Tintelen JP, van Veldhuisen DJ, et al. Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy. Circulation. 2010;121:2169-75.
20. Hilfiker-Kleiner D, Kaminski K, Podewski E, et al. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell. 2007;128:589-600.
21. Selle T, Renger I, Labidi S, et al. Reviewing peripartum cardiomyopathy: current state of knowledge. Future Med. 2009;5:175-89.
22. Ray P, Murphy J, Shutt L, et al. Recognition and management of maternal cardiac disease in pregnancy. Br J Anaesth. 2004;93:428-39.
23. Geva T, Mauer MB, Striker L, et al. Effects of physiologic load of pregnancy on left ventricular contractility and remodeling. Am Heart J. 1997;133:53-9.
24. Mouquet F, Lions C, de Groote P, et al. Characterisation of peripartum cardiomyopathy by cardiac magnetic resonance imaging. Eur Radiol. 2008;18:2765-9.
25. Hameed A, Chan K, Ghamsary M, et al. Longitudinal changes in the B-type natriuretic peptide levels in the normal pregnancy and postpartum. Clin Cardiol. 2009;32:60-2.
26. Forster O, Hilfiker-Kleiner D, Ansari AA, et al. Reversal of IFN-γ, oxLDL and prolactin serum levels correlate with clinical improvement in patients with peripartum cardiomyopathy. Eur J Heart Fail. 2008;10:861-8.
27. Baughman K. Peripartum cardiomyopathy. Curr Treat Options Cardiovasc Med. 2001;3:469-80.
28. Hopp L, Haider B, Iffy L. Myocardial infarction postpartum in patients taking bromocriptine for the prevention of breast engorgement. Int J Cardiol. 1996;57:227-32.
29. Amos AM, Jaber W, Russell SD. Improved outcome in peripartum cardiomyopathy with contemporary. Am Heart J. 2006;152:509-13.
30. Mielniczuk LM, Williams K, Dadvis DR, et al. Frequency of peripartum cardiomyopathy. Am J Cardiol. 2006;97:1765-8.
31. Brar SS, Khan SS, Sandhu GK, et al. Incidence, mortality and racial differences in peripartum cardiomyopathy. Am J Cardiol. 2007;100:302-4.
32. Sliwa K, Skundicky D, Bergemann A, et al. Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1. J Am Coll Cardiol. 2000;35:701-5.
33. Lampert MB, Weinert L, Hibbard J, et al. Contractile reserve in patients with peripartum cardiomyopathy and recovered left ventricular function. Am J Obstet Gynecol. 1997;176:189-95.
34. Elkayam U. Pregnant after peripartum cardiomyopathy: to be or not to be? Eur Heart J. 2002;23:753-6.